Examines how outer membrane vesicles from Bacteroides fragilis impact CFTR chloride secretion in human colon organoids, suggesting a new mechanism of host-pathogen interaction.
The goals of this study were to develop a model to study host-pathogen interactions in primary human colon organoids and to test the hypothesis that Bacteroides fragilis toxin (BFT-2) secreted in outer membrane vesicles (OMVs) modulates mucosal immunity and CFTR Cl⁻ secretion. Since Bacteroides species reside in mucus, OMVs are likely to represent a mechanism of communication between Bacteroides and the host. Two strains of Bacteroides were studied: enterotoxigenic Bacteroides fragilis (ETBF), which produces BFT-2, and the non-toxigenic Bacteroides fragilis strain NCTC 9343 (NTBF), which does not produce BFT-2. We also utilized two additional strains of Bacteroides fragilis : one in which bft -2 was knocked out (ETBF Δ bft ) and one that was engineered to contain bft-2 (NTBF+ bft ). We report that Bacteroides fragilis OMVs reduced CFTR Cl⁻ secretion, but had no effect on tight junction or cell adhesion proteins, transepithelial resistance (TER), or cytokine secretion by primary human colon organoids. NTBF OMVs containing BFT-2 were more effective in reducing CFTR Cl - secretion than NTBF lacking BFT-2. By contrast, deletion of bft in ETBF did not have a significant effect on CFTR Cl⁻ secretion compared to ETBF. We conclude that OMVs secreted by Bacteroides can be an important mechanism of host-pathogen interactions in the colon by reducing CFTR Cl⁻ secretion, and that the effect of BFT-2 on CFTR Cl⁻ secretion is dependent on the strain of Bacteroides fragilis .
No takes yet. Share an insight, caveat, or question.
Barnaby et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: